Press release
Neuroimmunology Drugs Market Exclusive Report on the Latest Revenue and Future Scope
The Neuroimmunology Drugs Market is valued at 21.84 Billion in 2022 and is predicted to reach 41.48 Billion by the year 2031 at a 7.55 % CAGR during the forecast period for 2023-2031.
Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1171
Neuroimmunological disorders are diseases that appear to be caused by the immune system attacking the nervous system (central or peripheral). A neuroimmunology drug aims to regulate immune system activity to treat neurological diseases with underlying immune pathologies. For treating neurological conditions, various neuroimmunology therapeutic strategies are being researched and used, including medicines that Product different cytokine subtypes, medications that bind only to specific receptors, and drugs that affect the migration of immune cells.
In the coming forecasting period, the presence of a large number of drugs in the pipeline for the treatment of neuroimmunology diseases such as Multiple Sclerosis (M.S.) and Alzheimer's disease (A.D.) is likely to create enormous opportunities for the market.
Biogen and Eisai had launched several initiatives to assist patients with Alzheimer's disease in gaining access to ADUHELMTM. It is the first new Alzheimer's treatment approved in the United States. These initiatives seek to assist patients and their families in understanding the disease, navigating the diagnostic process, obtaining culturally competent care, and affording treatment. Currently, there are almost 220 neuroimmunology drugs in Phase I, II, III, and later stages of development. The rising prevalence of neuroimmunology diseases is expected to drive significant demand for advanced treatment options worldwide.
However, the high cost of mAb-based therapy may significantly impede the market growth.
However, research and development activities among research universities, hospitals, and market participants are expected to generate enormous opportunities for global market growth.
Considering the high R&D spending and rapid research on dementia, immunology diseases, and strong product pipeline, North America is expected to lead the neuroimmunology market during the forecast period, followed by Europe. Furthermore, significant funding for Alzheimer's Disease will be responsible for the growth in upcoming forecast period.
Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1171
Major market players operating in the market includes F. Hoffmann-La Roche Ltd, Biogen, AstraZeneca Plc, Johnson & Johnson, Merck KGaA, Novartis AG, Sanofi, UCB SA, Eisai Co Ltd, Eli Lilly, AB Science S.A., Actelion Pharmaceuticals Ltd., AstronauTx, Alector, AZTherapies Inc., Celgene Corp., INmune Bio, Inc., Lundbeck, Genetech Inc., Grifols SA, Tiaki Therapeutics, T.G. Therapeutics Inc., AevisBio Inc., Monument Tx, ImmunoBrain Checkpoint, Talisman Therapeutics, Inflammasome Therapeutics, T3D Therapeutics, TauRX Therapeutics Ltd and among others.
Key Developments In The Market:
• In Jan 2022, Exscientia and Sanofi announced a ground-breaking research partnership and licence agreement to create up to 15 novel small molecule candidates in the fields of immunology and oncology by utilizing Exscientia's end-to-end AI-driven platform and real patient samples.
• In June 2021, the European Commission approved Roche's Enspryng for use in neuromyelitis optical spectrum disorder (NMOSD). Roche is trying to distinguish Enspryng from Alexion's Soliris in the E.U. by using subcutaneous administration, which could support dosing at home.
• In Aug 2020, Johnson & Johnson will purchase Momenta Pharmaceuticals, Inc., strengthening Janssen's position as a leader in cutting-edge therapies for autoimmune diseases. Nipocalimab (M281), a clinically proven and possibly best-in-class anti-FcRn antibody, will be included in the deal with full worldwide rights. Acquisition of Momenta for $6.5 billion through an all-cash tender offer priced at $52.50 per share.
• In Jan 2020, Biogen to Acquire Novel Clinical Stage Asset with Application in Alzheimer's Disease (A.D.) and Parkinson's Disease (P.D.) from Pfizer Inc. The agreement will include a $75 million upfront payment, up to $635 million in potential future commercialization and development milestone payments, and tiered royalties ranging from the high single digits to the low teens.
Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1171
Global Neuroimmunology Drugs Market, by By Indications, 2022-2030 (Value US$ Mn)
• Alzheimer's disease (A.D.)
• Multiple Sclerosis (M.S.)
• Parkinson's Disease (P.D.)
• Myasthenia Gravis (M.G.)
• Neuromyelitis Optica Spectrum Disorder (NMOSD)
• Guillain-Barre Syndrome (GBS)
• Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
• Amyotrophic Lateral Sclerosis (ALS)
• Others
Global Neuroimmunology Drugs Market, by Product Type, 2022-2030 (Value US$ Mn)
• Small Molecules
• Monoclonal Antibodies
• Recombinant Protein
• Others
Global Neuroimmunology Drugs Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Neuroimmunology Drugs Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Neuroimmunology Drugs Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Neuroimmunology Drugs Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Neuroimmunology Drugs Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Neuroimmunology Drugs Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
> To receive a comprehensive clinical trial/pipeline product analysis of the prospects for the global neuroimmunology drugs market
> To receive an industry overview and future trends of the neuroimmunology drugs market
> To analyze neuroimmunology drugs market drivers and challenges
> To get information on the neuroimmunology drugs market size (Value US$ Bn) forecast to 2030
> To get detailed insights regarding significant investments, mergers & acquisitions in the neuroimmunology drugs market industry
For More Information: https://www.insightaceanalytic.com/report/global-neuroimmunology-drugs-market-/1171
Global Neuropsychiatric Drugs Market
Global Neurodegenerative Disease Market
Global Preclinical Oncology Models Market
Global Immuno-Oncology Cell Therapy Market
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuroimmunology Drugs Market Exclusive Report on the Latest Revenue and Future Scope here
News-ID: 3329493 • Views: …
More Releases from Insightace analytic
Digital Pathology Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Pathology Market Size, Share & Trends Analysis Report By Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals)- Market Outlook And Industry Analysis 2031"
The global digital pathology market is estimated to reach over USD 2731.95 million by 2031, exhibiting a CAGR of 12.91%…
Digital Health Market Future Trends and Scope Analysis Report
Digital Health Market Size, Share & Trends Analysis Report By Technology (Tele-healthcare, mHealth, Healthcare Analytics, Digital Health Systems), By Component (Software, Hardware, Services), By Region, And Segment Forecasts, 2024-2031
"Digital Health Market" in terms of revenue was estimated to be worth $248.58 billion in 2023 and is poised to reach $1,004.03 billion by 2031, growing at a CAGR of 19.56% from 2023 to 2031, according to a new report by…
Digital Diabetes Management Market Report on the Untapped Growth Opportunities i …
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Diabetes Management Market - (By Devices (Smart Glucose Meters, Continuous Glucose Monitoring Systems, And Smart Insulin Pens, Smart Insulin Pumps/ Closed-Loop Pumps & Smart Insulin Patches), Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps), Data Management Software & Platforms And Services), By Device Type (Handheld And Wearable Devices), By End-User(Self/Home Healthcare, Hospitals…
Data Center Liquid Cooling Market Exclusive Trends Analysis with Forecast to 203 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Data Center Liquid Cooling Market Size, Share & Trends Analysis Report By End-User Industry (Financial Services And Insurance (BFSI), Banking, IT And Telecom, Government And Public Sector, Manufacturing, Healthcare, Retail), Data Center (Hyperscale, Colocation, Enterprise) And Solution (Indirect & Direct Cooling)- Market Outlook And Industry Analysis 2031"
The Global Data Center Liquid Cooling Market is estimated…
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
